These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 12948015)
1. Rapid assessment of P-glycoprotein inhibition and induction in vitro. Perloff MD; Störmer E; von Moltke LL; Greenblatt DJ Pharm Res; 2003 Aug; 20(8):1177-83. PubMed ID: 12948015 [TBL] [Abstract][Full Text] [Related]
2. Atazanavir: effects on P-glycoprotein transport and CYP3A metabolism in vitro. Perloff ES; Duan SX; Skolnik PR; Greenblatt DJ; von Moltke LL Drug Metab Dispos; 2005 Jun; 33(6):764-70. PubMed ID: 15764714 [TBL] [Abstract][Full Text] [Related]
3. Differential modulation of P-glycoprotein expression and activity by non-nucleoside HIV-1 reverse transcriptase inhibitors in cell culture. Störmer E; von Moltke LL; Perloff MD; Greenblatt DJ Pharm Res; 2002 Jul; 19(7):1038-45. PubMed ID: 12180537 [TBL] [Abstract][Full Text] [Related]
4. In vitro interaction of the HIV protease inhibitor ritonavir with herbal constituents: changes in P-gp and CYP3A4 activity. Patel J; Buddha B; Dey S; Pal D; Mitra AK Am J Ther; 2004; 11(4):262-77. PubMed ID: 15266218 [TBL] [Abstract][Full Text] [Related]
5. Selective inhibition of human cytochrome P450 3A4 by N-[2(R)-hydroxy-1(S)-indanyl]-5-[2(S)-(1, 1-dimethylethylaminocarbonyl)-4-[(furo[2, 3-b]pyridin-5-yl)methyl]piperazin-1-yl]-4(S)-hydroxy-2(R)-phenylmethy lpentanamide and P-glycoprotein by valspodar in gene transfectant systems. Kawahara I; Kato Y; Suzuki H; Achira M; Ito K; Crespi CL; Sugiyama Y Drug Metab Dispos; 2000 Oct; 28(10):1238-43. PubMed ID: 10997946 [TBL] [Abstract][Full Text] [Related]
6. P-glycoprotein and cytochrome P450 3A act together in restricting the oral bioavailability of paclitaxel. Hendrikx JJ; Lagas JS; Rosing H; Schellens JH; Beijnen JH; Schinkel AH Int J Cancer; 2013 May; 132(10):2439-47. PubMed ID: 23090875 [TBL] [Abstract][Full Text] [Related]
7. Inhibitors of mdr1-dependent transport activity delay accumulation of the mdr1 substrate rhodamine 123 in primary rat hepatocyte cultures. Hirsch-Ernst KI; Ziemann C; Rustenbeck I; Kahl GF Toxicology; 2001 Oct; 167(1):47-57. PubMed ID: 11557129 [TBL] [Abstract][Full Text] [Related]
8. Ritonavir induces P-glycoprotein expression, multidrug resistance-associated protein (MRP1) expression, and drug transporter-mediated activity in a human intestinal cell line. Perloff MD; Von Moltke LL; Marchand JE; Greenblatt DJ J Pharm Sci; 2001 Nov; 90(11):1829-37. PubMed ID: 11745741 [TBL] [Abstract][Full Text] [Related]
9. St John's Wort induces intestinal P-glycoprotein/MDR1 and intestinal and hepatic CYP3A4. Dürr D; Stieger B; Kullak-Ublick GA; Rentsch KM; Steinert HC; Meier PJ; Fattinger K Clin Pharmacol Ther; 2000 Dec; 68(6):598-604. PubMed ID: 11180019 [TBL] [Abstract][Full Text] [Related]
10. Modulation of P-glycoprotein function in human lymphocytes and Caco-2 cell monolayers by HIV-1 protease inhibitors. Profit L; Eagling VA; Back DJ AIDS; 1999 Sep; 13(13):1623-7. PubMed ID: 10509562 [TBL] [Abstract][Full Text] [Related]
11. Interplay between CYP3A-mediated metabolism and polarized efflux of terfenadine and its metabolites in intestinal epithelial Caco-2 (TC7) cell monolayers. Raeissi SD; Hidalgo IJ; Segura-Aguilar J; Artursson P Pharm Res; 1999 May; 16(5):625-32. PubMed ID: 10350002 [TBL] [Abstract][Full Text] [Related]
13. Piperine, a major constituent of black pepper, inhibits human P-glycoprotein and CYP3A4. Bhardwaj RK; Glaeser H; Becquemont L; Klotz U; Gupta SK; Fromm MF J Pharmacol Exp Ther; 2002 Aug; 302(2):645-50. PubMed ID: 12130727 [TBL] [Abstract][Full Text] [Related]
14. Ritonavir and dexamethasone induce expression of CYP3A and P-glycoprotein in rats. Perloff MD; von Moltke LL; Greenblatt DJ Xenobiotica; 2004 Feb; 34(2):133-50. PubMed ID: 14985144 [TBL] [Abstract][Full Text] [Related]
15. Fexofenadine transport in Caco-2 cells: inhibition with verapamil and ritonavir. Perloff MD; von Moltke LL; Greenblatt DJ J Clin Pharmacol; 2002 Nov; 42(11):1269-74. PubMed ID: 12412827 [TBL] [Abstract][Full Text] [Related]
16. Potent in vitro inhibition of CYP3A4 and P-glycoprotein by Rhodiola rosea. Hellum BH; Tosse A; Hoybakk K; Thomsen M; Rohloff J; Georg Nilsen O Planta Med; 2010 Mar; 76(4):331-8. PubMed ID: 19790032 [TBL] [Abstract][Full Text] [Related]
17. Characterizing the expression of CYP3A4 and efflux transporters (P-gp, MRP1, and MRP2) in CYP3A4-transfected Caco-2 cells after induction with sodium butyrate and the phorbol ester 12-O-tetradecanoylphorbol-13-acetate. Cummins CL; Mangravite LM; Benet LZ Pharm Res; 2001 Aug; 18(8):1102-9. PubMed ID: 11587480 [TBL] [Abstract][Full Text] [Related]
18. Comparative studies to determine the selective inhibitors for P-glycoprotein and cytochrome P4503A4. Achira M; Suzuki H; Ito K; Sugiyama Y AAPS PharmSci; 1999; 1(4):E18. PubMed ID: 11741214 [TBL] [Abstract][Full Text] [Related]
19. Saint John's wort: an in vitro analysis of P-glycoprotein induction due to extended exposure. Perloff MD; von Moltke LL; Störmer E; Shader RI; Greenblatt DJ Br J Pharmacol; 2001 Dec; 134(8):1601-8. PubMed ID: 11739235 [TBL] [Abstract][Full Text] [Related]
20. Inhibitory potencies of 1,4-dihydropyridine calcium antagonists to P-glycoprotein-mediated transport: comparison with the effects on CYP3A4. Katoh M; Nakajima M; Yamazaki H; Yokoi T Pharm Res; 2000 Oct; 17(10):1189-97. PubMed ID: 11145223 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]